BRIEF-Astrazeneca Says Licensed Coronavirus-Neutralising Antibodies From Vanderbilt University

BRIEF-Astrazeneca Says Licensed Coronavirus-Neutralising Antibodies From Vanderbilt University

AstraZeneca PLC:

* ASTRAZENECA - LICENSED CORONAVIRUS-NEUTRALISING ANTIBODIES FROM VANDERBILT UNIVERSITY

* ASTRAZENECA - PLANS TO ADVANCE PAIR OF MABS INTO CLINICAL DEVELOPMENT AS POTENTIAL COMBINATION THERAPY FOR PREVENTION AND TREATMENT OF COVID-19 Source text: https://bit.ly/2XKEF2D Further company coverage:

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.